RAC fluked the bisantrene patent without knowing anything about FTO.
The only additional FTO information which RAC has which COH doesn't have (yet) are the Dominissini data and the CDx. But COH could easily reproduce these without our assistance if only we weren't preventing them from conducting clinical trials using bisantrene. So RAC's main contribution apart from permission to go ahead will be lamingtons and Bushells. How much is that worth?
RAC media coverage, page-1465
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.76 |
Change
-0.020(1.12%) |
Mkt cap ! $293.1M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.78 | $1.70 | $193.2K | 110.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1098 | $1.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.77 | 2281 | 1 |
View Market Depth
| Last trade - 13.05pm 02/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |